D-1878-2019 Class II Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-1878-2019 was initiated by Akorn, Inc. on Sep 17, 2019 and is designated Class II. Reason for recall: cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product… The recall status is terminated (terminated Aug 1, 2022). Affected quantity: 10,543 tubes.

Recall details

Product Type
Drugs
Report Date
Oct 2, 2019
Initiation Date
Sep 17, 2019
Termination Date
Aug 1, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10,543 tubes

Product description

Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-711-30

Reason for recall

cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.

Distribution pattern

Nationwide within the United States and Puerto Rico

Code information

Lot #: 9B21A, Exp. 1/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1878-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1878-2019. Report a data issue: hello@regdatalab.com.